Transcarent is planning to acquire Accolade for $621 million, the companies announced Wednesday. The two companies are very complementary and the deal gives Accolade a chance to turn things around after struggling in the public market, experts say.
The post Accolade Gets a Do-Over With Transcarent’s $621M Acquisition appeared first on MedCity News.
